Internal Medicine, Pulmonary Disease · Madison, WI
NPI
1356452833
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
700 S Park St
Madison, WI, 53715
Phone (608) 251-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
1,762 services
Medicare patients, 2024
356
Average age 72
Drug cost, 2024
$2.0M
1,877 prescriptions
Company payments, 2025
$4,174
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ibrahim Al-Sanouri was code 99233 (hospital e&m - subsequent), 707 times for 213 patients. In total Ibrahim Al-Sanouri billed 1,762 services in 35 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 707 | 213 | $89.63 | $63K |
| 99291 Critical Care E&M | Facility | 404 | 137 | $160.63 | $65K |
| 99223 Hospital E&M - Initial | Facility | 82 | 73 | $126.55 | $10K |
| 99214 Office E&M - Established | Office | 62 | 49 | $90.56 | $5,615 |
| 94060 Pulmonary Function Testing | Office | 44 | 43 | $27.12 | $1,193 |
| 94729 Pulmonary Function Testing | Office | 39 | 39 | $40.87 | $1,594 |
| 94726 Pulmonary Function Testing | Office | 39 | 39 | $39.33 | $1,534 |
| 99215 Office E&M - Established | Office | 28 | 25 | $111.15 | $3,112 |
| 71046 X-ray - Chest | Office | 28 | 22 | $24.60 | $689 |
| 31624 Bronchoscopy | Facility | 15 | 11 | $86.86 | $1,303 |
| 36620 Vascular | Facility | 14 | 11 | $33.25 | $466 |
| 36556 Venous Catheter Insertion | Facility | 14 | 13 | $62.81 | $879 |
By year: 2022 $158K for 1,812 services; 2023 $165K for 1,806 services; 2024 $161K for 1,762 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ibrahim Al-Sanouri prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 307 prescriptions and refills. In total Ibrahim Al-Sanouri wrote 1,877 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 307 | 470 | 82 | $289K |
| Dupixent Pen Dupilumab | 260 | 260 | 35 | $970K |
| Montelukast Sodium Generic | 150 | 319 | 49 | $2,128 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 115 | 161 | 41 | $5,376 |
| Fluticasone Propionate Generic | 89 | 151 | 33 | $1,300 |
| Ventolin Hfa Albuterol Sulfate | 85 | 129 | 28 | $8,235 |
| Prednisone Generic | 78 | 85 | 45 | $401 |
| Levocetirizine Dihydrochloride Generic | 74 | 102 | 21 | $556 |
| Promethazine Hcl Generic | 72 | 72 | 11 | $1,004 |
| Symbicort Budesonide/Formoterol Fumarate | 62 | 102 | 21 | $22K |
| Spiriva Respimat Tiotropium Bromide | 53 | 93 | 16 | $46K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 49 | 79 | 14 | $8,708 |
| Tezspire Tezepelumab-Ekko | 46 | 46 | Under 11 | $200K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 43 | 67 | 15 | $41K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 41 | 99 | 20 | $21K |
Brand drugs: 1,164 claims; generic drugs: 713 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ibrahim Al-Sanouri $4,174 ($4,174 in general payments such as food, travel and fees) from 11 companies. The largest payer was Intuitive Surgical, Inc. with $3,471.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 7 | $3,471 |
| GlaxoSmithKline, LLC. GSK | 10 | $208 |
| Amgen Inc. AMGN | 12 | $164 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $120 |
| Insmed, Inc. INSM | 3 | $77.32 |
| Pulmonx Corporation LUNG | 2 | $40.03 |
| Pfizer Inc. PFE | 1 | $23.97 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $20.42 |
| 3B Medical, Inc. | 1 | $17.62 |
| Lilly USA, LLC LLY | 1 | $17.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.